Assistant Professor
General Surgery
Dr. Alexander A. Parikh, MD
|
|
Give Review
Alexander Parikh is an expert in the field of General Surgery. He researched medicine at University Hospital - University of Cincinnati College of Medicine. He over the years received 3 awards: "Regional Top Doctor", "Meaningful Use Stage 1 Certification" and "Fellow (FACS)". Alexander Parikh is a published doctor as well. He has 83 publications published. The latest was: Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs. Alexander A. Parikh is registered with Medicare and accepts Medicare payments.
Publications
- Cholangiocarcinoma arising from intraductal papillary mucinous neoplasm of the bile duct.
- Perioperative chemotherapy for resectable colorectal hepatic metastases-What does the EORTC 40983 trial update mean?
- Peri-operative risk factors for delayed gastric emptying after a pancreaticoduodenectomy.
- Incidence of additional primary malignancies in patients with pancreatic and gastrointestinal neuroendocrine tumors.
- Cadherin 17 is frequently expressed by 'sclerosing variant' pancreatic neuroendocrine tumour.
- Value of intraoperative neck margin analysis during whipple for pancreatic adenocarcinoma: a multicenter analysis of 1399 patients.
- Perioperative Blood Transfusion Is Associated with Decreased Survival in Patients Undergoing Pancreaticoduodenectomy for Pancreatic Adenocarcinoma: a Multi-institution...
- The effect of health insurance status on the treatment and outcomes of patients with colorectal cancer.
- Epidermal growth factor receptor signaling pathway is frequently altered in ampullary carcinoma at protein and genetic levels.
- Trends in the Multimodality Treatment of Resectable Colorectal Liver Metastases: an Underutilized Strategy.
- Vein Involvement During Pancreaticoduodenectomy: Is There a Need for Redefinition of "Borderline Resectable Disease"?
- Revision of cemented hip arthroplasty using a hydroxyapatite-ceramic-coated femoral component.
- The holmium: YAG laser for ureteric stones.
- The burden of screening for acoustic neuroma: asymmetric otological symptoms in the ENT clinic.
- Effects of non-steroidal anti-inflammatory drugs on cyclo-oxygenase and lipoxygenase activity in whole blood from aspirin-sensitive asthmatics vs healthy donors.
- Twenty years of biochemistry of human P450s: purification, expression, mechanism, and relevance to drugs.
- Blunt carotid artery injuries.
- What makes P450s work? Searches for answers with known and new P450s.
- Implementation of a clinical pathway decreases length of stay and cost for bowel resection.
- Random mutagenesis by whole-plasmid PCR amplification.
- Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
- Interleukin-6 production in human intestinal epithelial cells increases in association with the heat shock response.
- Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
- Reactive intermediates in biological systems: what have we learned and where are we going?
- Clonogenic analysis reveals reserve stem cells in postnatal mammals: I. Pluripotent mesenchymal stem cells.
- Inter-individual differences in the metabolism of environmental toxicants: cytochrome P450 1A2 as a prototype.
- Drug metabolism by Escherichia coli expressing human cytochromes P450.
- Interleukin-1 beta and interferon-gamma regulate interleukin-6 production in cultured human intestinal epithelial cells.
- Stress response decreases the interleukin-1beta-induced production of complement component C3 in human intestinal epithelial cells.
- Interleukin-1beta induces complement component C3 and IL-6 production at the basolateral and apical membranes in a human intestinal epithelial cell line.
- IL-6 production in human intestinal epithelial cells following stimulation with IL-1 beta is associated with activation of the transcription factor NF-kappa B.
- Expression of drug-metabolizing enzymes.
- Endothelial survival factors as targets for antineoplastic therapy.
- Complement component C3 production in IL-1beta-stimulated human intestinal epithelial cells is blocked by NF-kappaB inhibitors and by transfection with ser 32/36 mutan...
- Chemoresistant colorectal cancer cells and cancer stem cells mediate growth and survival of bystander cells.
- Pancreatic cancer: can we screen? How should we stage?
- Complement C3 production in human intestinal epithelial cells is regulated by interleukin 1beta and tumor necrosis factor alpha.
- Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts.
- IL-1beta induction of NF-kappaB activation in human intestinal epithelial cells is independent of oxyradical signaling.
- Risk of malignancy in resected cystic tumors of the pancreas < or =3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report.
- The role of the microenvironment and intercellular cross-talk in tumor angiogenesis.
- Role of angiogenesis in the development and growth of liver metastasis.
- Angiopoietin-1 inhibits tumour growth and ascites formation in a murine model of peritoneal carcinomatosis.
- Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells.
- Promises and pitfalls of anti-angiogenic therapy in clinical trials.
- Laparoscopic left pancreatectomy: complication risk score correlates with morbidity and risk for pancreatic fistula.
- Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis.
- Impact of insulin-like growth factor receptor-I function on angiogenesis, growth, and metastasis of colon cancer.
- Angiopoietins and their role in colon cancer angiogenesis.
- Radiofrequency ablation of hepatic metastases.
- Antiangiogenic therapy targeting factors that enhance endothelial cell survival.
- Role of P38 MAPK, AP-1, and NF-kappaB in interleukin-1beta-induced IL-8 expression in human vascular smooth muscle cells.
- Synopsis of angiogenesis inhibitors in oncology.
- Endoscopic ultrasound and computed tomography predictors of pancreatic cancer resectability.
- Regulation of cyclooxygenase-2 (COX-2) expression in human pancreatic carcinoma cells by the insulin-like growth factor-I receptor (IGF-IR) system.
- Upregulation of neuropilin-1 by basic fibroblast growth factor enhances vascular smooth muscle cell migration in response to VEGF.
- The vascular endothelial growth factor family and its receptors.
- Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis.
- Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy.
- Regulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and angiogenesis by an insulin-like growth factor-I receptor autocrine loop in human...
- Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma.
- Cyclooxygenase-2 is up-regulated by interleukin-1 beta in human colorectal cancer cells via multiple signaling pathways.
- Angiopoietin-1 inhibits vascular permeability, angiogenesis, and growth of hepatic colon cancer tumors.
- Alphavbeta3 integrin antagonist S247 decreases colon cancer metastasis and angiogenesis and improves survival in mice.
- Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in m...
- Biology of angiogenesis in tumors of the gastrointestinal tract.
- Gastric schwannoma.
- Genomics and proteomics in predicting cancer outcomes.
- Shifting trends in liver-directed management of patients with colorectal liver metastasis: A population-based analysis.
- Circulating angiogenic factors, tumor cells, and outcome after resection of metastatic colorectal cancer--what does it mean?
- Laparoscopic versus open left pancreatectomy: can preoperative factors indicate the safer technique?
- Adjuvant chemoradiation therapy for pancreas cancer: who really benefits?
- Appendiceal adenocarcinoma presenting as venous thromboembolism: an unusual presentation of a rare carcinoma.
- A multicenter analysis of distal pancreatectomy for adenocarcinoma: is laparoscopic resection appropriate?
- Update on adjuvant trials for pancreatic cancer.
- Should all distal pancreatectomies be performed laparoscopically?
- Adjuvant chemoradiation therapy for pancreatic adenocarcinoma: who really benefits?
- Improvement of survival with response to neoadjuvant radiation therapy for rectal cancer.
- Left-sided pancreatectomy: a multicenter comparison of laparoscopic and open approaches.
- Analysis of 6,747 pancreatic neuroendocrine tumors for a proposed staging system.
- Operative considerations in resection of hilar cholangiocarcinoma.
- Advances in the Surgical Management of Resectable and Borderline Resectable Pancreas Cancer.
Schools
Univ Of Pa Sch Of Med
Procedures Preformed
- Adrenalectomy
- Appendectomy, Laparoscopic
- Biliary Drainage
- Colectomy
- View All
Doctors Specialties
- Surgical Oncology
- General Surgery
Accepted Insurances
Awards
- Regional Top Doctor
- Meaningful Use Stage 1 Certification
- Fellow (FACS)
Education
-
Vanderbilt University -
University of Texas MD Anderson Cancer Center -
University Hospital - University of Cincinnati College of Medicine -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Vanderbilt Hospital and Clinics
Drug Facts
| NPI NUMBER | 1174610208 | |
| NPPES Provider LastName | PARIKH | |
| NPPES Provider FirstName | ALEXANDER | |
| NPPES Provider ZIPCode | 372320001 | |
| NPPES Provider State | TN | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 163.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 14.0 | |
| Percent Opioid Claims | 8.59 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1174610208 |
| Last Name Of The Provider | PARIKH |
| First Name Of The Provider | ALEXANDER |
| View All |
Similar Doctors
|
Dr. Carmen C. Solorzano, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Richard A. Pierce, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kamran Idrees, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Mary A. Hooks, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Naira Baregamian, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sunil K. Geevarghese, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ana M. Grau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Muhammad Aslam, MD |
|
|
Dr. James R. Goldenring, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Jamie R. Robinson, MD |
|
|
Igor V. Voskresensky |